Potassium Citrate Tablet, Extended Release
Product Images NDC 70518-4477

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Potassium Citrate (NDC 70518-4477). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Remedy_label (Remedy Label)

Packaging label for Potassium Citrate extended-release tablets, 10 mEq (1080 mg) strength. The label indicates a quantity of 100 tablets in a yellow capsule form marked T400. Manufactured by Camber Pharma, Inc., repackaged by RemedyRepack Inc., Indiana, PA. Storage instructions and child safety warnings are included.*

FDA Label Image

Structure (Structure)

Chemical structure of Potassium Citrate with three potassium carboxylate groups and one hydroxyl group bonded to a central carbon, shown as its monohydrate form including one water molecule.*

FDA Label Image

Table 1. (Table 1.)

Data table titled 'Effect of Potassium Citrate In Patients With Calcium Oxalate Nephrolithiasis' showing stones formed per year across four patient groups at baseline, on treatment, remission percentage, and any decrease percentage. The table includes total values and a footnote defining remission as the percentage of patients free of new stones during treatment.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.